• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征尸检脑组织中 tau 和淀粉样蛋白 PET 示踪剂的区域结合。

Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.

机构信息

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Knoebel Institute for Healthy Aging (KIHA), University of Denver, Denver, CO, USA.

出版信息

Mol Neurodegener. 2020 Nov 23;15(1):68. doi: 10.1186/s13024-020-00414-3.

DOI:10.1186/s13024-020-00414-3
PMID:33222700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7682014/
Abstract

INTRODUCTION

Tau pathology is a major age-related event in Down syndrome with Alzheimer's disease (DS-AD). Although recently, several different Tau PET tracers have been developed as biomarkers for AD, these tracers showed different binding properties in Alzheimer disease and other non-AD tauopathies. They have not been yet investigated in tissue obtained postmortem for DS-AD cases. Here, we evaluated the binding characteristics of two Tau PET tracers (H-MK6240 and H-THK5117) and one amyloid (H-PIB) ligand in the medial frontal gyrus (MFG) and hippocampus (HIPP) in tissue from adults with DS-AD and DS cases with mild cognitive impairment (MCI) compared to sporadic AD.

METHODS

Tau and amyloid autoradiography were performed on paraffin-embedded sections. To confirm respective ligand targets, adjacent sections were immunoreacted for phospho-Tau (AT8) and stained for amyloid staining using Amylo-Glo.

RESULTS

The two Tau tracers showed a significant correlation with each other and with AT8, suggesting that both tracers were binding to Tau deposits. H-MK6240 Tau binding correlated with AT8 immunostaining but to a lesser degree than the H-THK5117 tracer, suggesting differences in binding sites between the two Tau tracers. H-THK5117, H-MK6240 and H-PIB displayed dense laminar binding in the HIPP and MFG in adult DS brains. A regional difference in Tau binding between adult DS and AD was observed suggesting differential regional Tau deposition in adult DS compared to AD, with higher THK binding density in the MFG in adult with DS compared to AD. No significant correlation was found between H-PIB and Amylo-Glo staining in adult DS brains suggesting that the amyloid PIB tracer binds to additional sites.

CONCLUSIONS

This study provides new insights into the regional binding distribution of a first-generation and a second-generation Tau tracer in limbic and neocortical regions in adults with DS, as well as regional differences in Tau binding in adult with DS vs. those with AD. These findings provide new information about the binding properties of two Tau radiotracers for the detection of Tau pathology in adults with DS in vivo and provide valuable data regarding Tau vs. amyloid binding in adult DS compared to AD.

摘要

简介

在唐氏综合征伴阿尔茨海默病(DS-AD)中,tau 病理学是与年龄相关的主要事件。尽管最近已经开发出几种不同的 Tau PET 示踪剂作为 AD 的生物标志物,但这些示踪剂在 AD 和其他非 AD tau 病中的结合特性不同。它们尚未在 DS-AD 病例的死后组织中进行研究。在这里,我们评估了两种 Tau PET 示踪剂(H-MK6240 和 H-THK5117)和一种淀粉样蛋白(H-PIB)配体在 DS-AD 成人和 DS 伴有轻度认知障碍(MCI)患者的内侧额回(MFG)和海马(HIPP)中的结合特征,与散发性 AD 相比。

方法

对石蜡包埋切片进行 Tau 和淀粉样蛋白放射自显影。为了确认各自的配体靶标,用磷酸化 Tau(AT8)进行相邻切片的免疫反应,并使用 Amylo-Glo 对淀粉样蛋白染色进行染色。

结果

两种 Tau 示踪剂彼此之间以及与 AT8 之间存在显著相关性,表明这两种示踪剂均与 Tau 沉积物结合。H-MK6240 Tau 结合与 AT8 免疫染色相关,但程度低于 H-THK5117 示踪剂,表明两种 Tau 示踪剂之间的结合部位存在差异。H-THK5117、H-MK6240 和 H-PIB 在成人 DS 大脑的 HIPP 和 MFG 中显示出密集的层状结合。在成人 DS 和 AD 之间观察到 Tau 结合的区域差异,表明与 AD 相比,成人 DS 中 Tau 沉积存在差异,与 AD 相比,成人 DS 中 MFG 中的 THK 结合密度更高。在成人 DS 大脑中,未发现 H-PIB 与 Amylo-Glo 染色之间存在显著相关性,表明淀粉样蛋白 PIB 示踪剂结合到其他部位。

结论

本研究为在成人 DS 中,第一代和第二代 Tau 示踪剂在边缘和新皮质区域的区域结合分布以及成人 DS 中 Tau 结合的区域差异提供了新的见解,与 AD 相比。这些发现为在成人 DS 中体内检测 Tau 病理学的两种 Tau 放射性示踪剂的结合特性提供了新的信息,并提供了有关 Tau 与淀粉样蛋白结合的有价值的数据,与 AD 相比,在成人 DS 中。

相似文献

1
Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.唐氏综合征尸检脑组织中 tau 和淀粉样蛋白 PET 示踪剂的区域结合。
Mol Neurodegener. 2020 Nov 23;15(1):68. doi: 10.1186/s13024-020-00414-3.
2
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.MK6240 是一种 tau PET 示踪剂,在阿尔茨海默病患者尸检脑组织中的特征分析。
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1093-1102. doi: 10.1007/s00259-020-05035-y. Epub 2020 Sep 24.
3
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.tau PET 示踪剂 PI2620、MK6240 和 RO948 在阿尔茨海默病、皮质基底节变性和进行性核上性麻痹脑中的鉴别结合。
Mol Psychiatry. 2023 Mar;28(3):1272-1283. doi: 10.1038/s41380-022-01875-2. Epub 2022 Nov 29.
4
Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by H-THK5117 and H-deprenyl autoradiography.阿尔茨海默病中海马 H-THK5117 和 H-去甲丙炔苯丙胺放射性自显影可见皮质层状 tau 沉积物和活化星形细胞。
Sci Rep. 2017 Apr 4;7:45496. doi: 10.1038/srep45496.
5
Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.使用(3)H-THK5117 观察阿尔茨海默病脑组织中的局部 tau 沉积物。
Acta Neuropathol Commun. 2015 Jul 2;3:40. doi: 10.1186/s40478-015-0220-4.
6
Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.tau PET 示踪剂 THK5117、THK5351、PBB3 和 T807 在阿尔茨海默病死后大脑中的比较结合特性。
Alzheimers Res Ther. 2017 Dec 11;9(1):96. doi: 10.1186/s13195-017-0325-z.
7
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9.常染色体显性阿尔茨海默病变异:AβPParc 和 PSEN1DE9 中的淀粉样蛋白、tau 和星形胶质细胞病理学。
Mol Psychiatry. 2021 Oct;26(10):5609-5619. doi: 10.1038/s41380-020-0817-2. Epub 2020 Jun 25.
8
The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study.阿尔茨海默病中神经炎症、β-淀粉样蛋白和 tau 沉积之间的关系:一项纵向 PET 研究。
J Neuroinflammation. 2020 May 6;17(1):151. doi: 10.1186/s12974-020-01820-6.
9
Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.采用多模态范式,利用THK5317正电子发射断层扫描(PET)对阿尔茨海默病体内的tau病理进行成像。
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1686-99. doi: 10.1007/s00259-016-3363-z. Epub 2016 Mar 21.
10
S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.S-[18F]THK-5117-PET 和 [11C]PIB-PET 成像在特发性正常压力脑积水与脑活检中确认的淀粉样蛋白-β斑块和 Tau 的关系。
J Alzheimers Dis. 2018;64(1):171-179. doi: 10.3233/JAD-180071.

引用本文的文献

1
Charting the future: current and future directions in translational research for individuals with Down syndrome.规划未来:唐氏综合征患者转化研究的现状与未来方向
J Neurodev Disord. 2025 Jul 8;17(1):38. doi: 10.1186/s11689-025-09630-8.
2
Feasibility and potential diagnostic value of [F]PI-2620 PET in patients with down syndrome and Alzheimer's disease: a case series.[F]PI - 2620正电子发射断层显像(PET)在唐氏综合征和阿尔茨海默病患者中的可行性及潜在诊断价值:病例系列研究
Front Neurosci. 2025 Jan 6;18:1505999. doi: 10.3389/fnins.2024.1505999. eCollection 2024.
3
Comparison between DSQIID total / sub-item scores and plasma p-tau elevation in adults with Down's syndrome.

本文引用的文献

1
Tau PET imaging in neurodegenerative tauopathies-still a challenge.神经退行性 tau 病中的 tau PET 成像——仍然是一个挑战。
Mol Psychiatry. 2019 Aug;24(8):1112-1134. doi: 10.1038/s41380-018-0342-8. Epub 2019 Jan 11.
2
Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.认知综合评分与阿尔茨海默病斑块和缠结病理的关联。
Alzheimers Res Ther. 2018 Sep 11;10(1):90. doi: 10.1186/s13195-018-0401-z.
3
Aging related cognitive changes associated with Alzheimer's disease in Down syndrome.唐氏综合征中与阿尔茨海默病相关的衰老性认知变化。
唐氏综合征成人患者DSQIID总分/子项得分与血浆p- tau升高情况的比较。
PLoS One. 2024 Dec 9;19(12):e0311878. doi: 10.1371/journal.pone.0311878. eCollection 2024.
4
The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome.tau蛋白病理在阿尔茨海默病和唐氏综合征中的作用。
J Clin Med. 2024 Feb 27;13(5):1338. doi: 10.3390/jcm13051338.
5
Down Syndrome Biobank Consortium: A perspective.唐氏综合征生物样本库联盟:一个视角。
Alzheimers Dement. 2024 Mar;20(3):2262-2272. doi: 10.1002/alz.13692. Epub 2024 Jan 25.
6
Amyloid-beta and tau protein beyond Alzheimer's disease.阿尔茨海默病之外的β淀粉样蛋白和tau蛋白。
Neural Regen Res. 2024 Jun 1;19(6):1262-1276. doi: 10.4103/1673-5374.386406. Epub 2023 Oct 2.
7
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.神经变性中的氧化损伤:阿尔茨海默病发病机制和进展中的作用。
Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022.
8
The therapeutic landscape of tauopathies: challenges and prospects.tau 病治疗景观:挑战与展望。
Alzheimers Res Ther. 2023 Oct 6;15(1):168. doi: 10.1186/s13195-023-01321-7.
9
Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook.使用PET配体对tau蛋白病进行成像:现状与未来展望
Diagnostics (Basel). 2023 May 9;13(10):1682. doi: 10.3390/diagnostics13101682.
10
Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.液-液相分离促进帕金森病痴呆中的蛋白质聚集及其在铁死亡中的意义。
Oxid Med Cell Longev. 2022 Oct 6;2022:7165387. doi: 10.1155/2022/7165387. eCollection 2022.
Ann Clin Transl Neurol. 2018 May 20;5(6):741-751. doi: 10.1002/acn3.571. eCollection 2018 Jun.
4
S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.S-[18F]THK-5117-PET 和 [11C]PIB-PET 成像在特发性正常压力脑积水与脑活检中确认的淀粉样蛋白-β斑块和 Tau 的关系。
J Alzheimers Dis. 2018;64(1):171-179. doi: 10.3233/JAD-180071.
5
Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding.tau蛋白病中的tau正电子发射断层扫描成像:非靶向结合带来的额外障碍。
Alzheimers Dement (Amst). 2018 Feb 23;10:232-236. doi: 10.1016/j.dadm.2018.01.007. eCollection 2018.
6
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls.在体鉴定和定量研究人类神经纤维缠结 Tau PET 放射性配体 F-MK-6240 从阿尔茨海默病痴呆到年轻对照的变化。
J Nucl Med. 2019 Jan;60(1):93-99. doi: 10.2967/jnumed.118.209650. Epub 2018 May 18.
7
Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling.不同正电子发射断层扫描 Tau 示踪剂与 Tau 纤维上的多个结合位点结合:来自计算建模的见解。
ACS Chem Neurosci. 2018 Jul 18;9(7):1757-1767. doi: 10.1021/acschemneuro.8b00093. Epub 2018 May 2.
8
Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.tau PET 示踪剂 THK5117、THK5351、PBB3 和 T807 在阿尔茨海默病死后大脑中的比较结合特性。
Alzheimers Res Ther. 2017 Dec 11;9(1):96. doi: 10.1186/s13195-017-0325-z.
9
Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.神经影像学及其他方法评估唐氏综合征患者的阿尔茨海默病。
Neuroimage Clin. 2017 Nov 6;17:263-271. doi: 10.1016/j.nicl.2017.10.022. eCollection 2018.
10
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).唐氏综合征中tau蛋白病理的PET成像及其与淀粉样蛋白、纵向MRI和认知变化的关系:唐氏综合征生物标志物倡议(DSBI)的结果
J Alzheimers Dis. 2017;60(2):439-450. doi: 10.3233/JAD-170390.